Shreeram Aradhye
ENG. Shreeram Aradhye has been Global Head, Medical Affairs and Chief Medical Officer - Pharmaceuticals , since February 2017. He is a member of the Pharma Executive Committee and a member of the Development Committee Novartis.
Prior to his current appointments, Shreeram has been the Global Head, Development Neuroscience for 3.5 years, after serving as Executive Global Program Head for the Multiple Sclerosis portfolio from 2012 to 2013 and Head Global Development India from 2011 to 2012. Prior to that, Shreeram Aradhye has held multiple leadership roles, including Head US Medical Affairs and Head Global Medical Affairs for Transplantation and Immunology, Senior Global Program Medical Director for Gilenya and Clinical Franchise Head for the Immunology and Infectious Diseases Franchise. He also served on a cross divisional assignment as the Head of Clinical Development and Medical Affairs for the Sandoz Biosimilars BU in 2010.
Before joining Novartis, Shreeram Aradhye was an Assistant Professor of Medicine and transplant nephrologist at the University of Pennsylvania, Philadelphia.
Shreeram Aradhye received his MD from the All India Institute of Medical Sciences in 1989 and received formal specialty training in internal medicine and Nephrology in the United States.
ITA. Shreeram Aradhye è Global Head, Medical Affairs e Chief Medical Officer di Novartis Pharmaceuticals dal febbraio del 2017. È inoltre membro del Pharma Executive Committee e del Development Committee dell'azienda.
Prima di questi incarichi, Shreeram è stato Global Head, Development Neuroscience per tre anni e mezzo, dopo aver lavorato come Executive Global Program Head per il portfolio Sclerosi Multipla dal 2012 al 2013 e Head Global Development India dal 2011 al 2012. In passato ha ricoperto diversi ruoli di responsabilità, tra cui Head US Medical Affairs e Head Global Medical Affairs per i trapianti e l'immunologia, Senior Global Program Medical Director per Gilenya e Clinical Franchise Head per l'Immunology and Infectious Diseases Franchise. Nel 2010 ha inoltre assunto l'incarico di Head of Clinical Development and Medical Affairs presso la business unit Sandoz Biosimilars.
Prima di entrare in Novartis, ha lavorato come assistente di medicina e nefrologo specializzato in trapianti presso l'Università della Pennsylvania a Philadelphia.
Ha conseguito la laurea in medicina nel 1989 presso l'All India Institute of Medical Sciences, per poi specializzarsi in medicina interna e nefrologia negli Stati Uniti
Re-imagining medicine
ENG. In a world more connected and in constant evolution than at any previous time in history, there are new ways to improve and extend people's lives. At Novartis we use science-based innovation and novel approaches to address some of society's most challenging healthcare issues by discovering, developing and delivering breakthrough treatments to deliver them as many people as possible. New and innovative processes and approaches will help us to better respond to the needs of our healthcare providers and patients. Each day we strive to change the practice of medicine in the interest of patients with unmet needs across the world.
Ripensare la medicina
ITA. In un mondo più connesso e in costante evoluzione rispetto a qualsiasi altra epoca storica, possiamo contare su soluzioni nuove per migliorare l'esistenza delle persone e prolungarne le aspettative di vita. Novartis sfrutta le innovazioni basate sulla scienza e applica approcci innovativi per affrontare alcune tra le problematiche sanitarie più gravi per la società, attraverso la scoperta, lo sviluppo e la diffusione di cure all'avanguardia a beneficio del maggior numero di pazienti possibile. L'applicazione di processi e metodi innovativi ci consentirà di rispondere al meglio alle esigenze delle strutture sanitarie e delle persone. Ci impegniamo quotidianamente per modificare la pratica medica nell'interesse dei pazienti in tutto il mondo che non hanno ancora trovato risposta alle loro necessità.
